<DOC>
	<DOCNO>NCT02209714</DOCNO>
	<brief_summary>The objective study obtain information safety tolerability BIIF 1149 BS45 ( single dose : 40 , 65 , 100 mg ) , determine pharmacologically active dose ( range ) perform citric acid challenge test obtain preliminary pharmacokinetic data .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacodynamics After Oral Administration BIIF 1149 BS Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male , base complete medical examination Age range 21 50 year +/ 20 % normal weight ( BrocaIndex ) Written informed consent Volunteers exclude study result medical examination laboratory test judge clinical investigator differ significantly normal clinical value Volunteers know gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Volunteers diseases central nervous system ( epilepsy ) psychiatric disorder Volunteers know history orthostatic hypotension , faint spell blackouts Volunteers chronic relevant acute infection ( especially respiratory infection , cough ) Volunteers history allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Volunteers take drug long halflife ( ≥ 24 hour ) within ten halflives respective drug enrolment study Volunteers receive drug might influence result study week prior start study Volunteers participate another study investigational drug within last 2 month precede study Volunteers smoke 10 cigarette ( equivalent ) per day Volunteers able refrain smoking study day Volunteers drink 40 g alcohol per day Volunteers dependent drug Volunteers participate excessive physical activity ( e.g . competitive sport ) last week study Volunteers donate blood ( ≥ 100 ml ) within last four week</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>